title: Bisphosphonate or RANK-L inhibitor for tumour-induced hypercalcaemia?
authors: A
authors: A
authors: Bech
authors: G
authors: G
authors: Essink
authors: H
authors: H
authors: de Boer
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000150:complications; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology*; D007680:Kidney Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged; D053245:RANK Ligand / Q000037:antagonists & inhibitors*
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D053245:RANK Ligand